Structure-function analyses of candidate small molecule RPN13 inhibitors with antitumor properties-Reference-Cited by-同舟云学术

Structure-function analyses of candidate small molecule RPN13 inhibitors with antitumor properties

Published:2020-01-15 Issue:1 Volume:15 Page:e0227727
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Anchoori Ravi K.,Tan Marietta,Tseng Ssu-Hsueh,Peng Shiwen,Soong Ruey-Shyang,Algethami Aliyah,Foran Palmer,Das Samarjit^ORCID,Wang Chenguang,Wang Tian-Li,Liang Hong,Hung Chien-Fu,Roden Richard B. S.^ORCID

Funder

National Institutes of Health

Allegheny Health Network

Ovarian Cancer Research Fund Alliance

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference59 articles.

1. Ubiquitin and intracellular protein degradation;M Hochstrasser;Curr Opin Cell Biol,1992

2. Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system;QP Dou;Curr Cancer Drug Targets,2014

3. Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial;A Broyl;Lancet Oncol,2010

4. Structure and energetics of pairwise interactions between proteasome subunits RPN2, RPN13, and ubiquitin clarify a substrate recruitment mechanism;RT VanderLinden;J Biol Chem,2017

5. Structural basis for the recognition of K48-linked Ub chain by proteasomal receptor Rpn13;Z Liu;Cell Discov,2019

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical studies of RA475, a guanidine-substituted spirocyclic candidate RPN13/ADRM1 inhibitor for treatment of ovarian cancer;PLOS ONE;2024-07-11

2. hRpn13 shapes the proteome and transcriptome through epigenetic factors HDAC8, PADI4, and transcription factor NF-κB p50;Molecular Cell;2024-02

3. Targeting endoplasmic reticulum stress signaling in ovarian cancer therapy;Cancer Biology & Medicine;2023-10-10

4. Exploiting the Proteasome for Disease Treatment;Protein Homeostasis in Drug Discovery;2022-11-14

5. Modulation of Cellular Redox Parameters for Improving Therapeutic Responses in Multiple Myeloma;Antioxidants;2022-02-25